Agneta Wennman-Larsen

Agneta Wennman-Larsen

Auto-generated profile, based on publicly available information

Agneta Wennman-Larsen

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2002 in Scandinavian Journal of Caring Sciences
Verified
Journal Article
Closed access
PDF file
AWAgneta Wennman‐Larsen
Agneta Wennman‐Larsen
CTCarol Tishelman
Carol Tishelman

1 July 2011 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
MNMarie Nilsson
Marie Nilsson
MOMariann Olsson
Mariann Olsson
AWAgneta Wennman-Larsen
Agneta Wennman-Larsen
LPLena-Marie Petersson
Lena-Marie Petersson
KAKristina Alexanderson
Kristina Alexanderson

20 September 2012 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
MNM. I. Nilsson
M. I. Nilsson
MOM. Olsson
M. Olsson
AWA. Wennman‐Larsen
A. Wennman‐Larsen
LPL.‐M. Petersson
L.‐M. Petersson
KAK. Alexanderson
K. Alexanderson

13 January 2011 in Acta Oncologica
Verified
Journal Article
Closed access
PDF file
LPLena-Marie Petersson
Lena-Marie Petersson
AWAgneta Wennman-Larsen
Agneta Wennman-Larsen
MNMarie Nilsson
Marie Nilsson
MOMariann Olsson
Mariann Olsson
KAKristina Alexanderson
Kristina Alexanderson
Background. Breast cancer is the most common cancer diagnosis in women, many of whom are of working age, and the five-year survival rate in Sweden is approaching 90%. Accordingly, aspects of working life and sickness absence are of increasing importance for breast cancer survivors and may have a long-term impact on health and quality of life of these women. The aim was to elucidate the work situation and sickness absence during the initial period after breast cancer surgery and to explore factors associated with sickness absence. Material and methods. This is a cross-sectional questionnaire study 4–6 weeks after breast cancer surgery of women aged 20–63 years, and living in Stockholm. A consecutive sample of 933 women were invited and 756 (81%) accepted to participate. Logistic regression analyses were computed to estimate crude and adjusted odds ratios for associations between sick leave and other variables. Results. Most women (86%) were employed (including self-employed) at diagnosis, and 91% of those worked ≥75% of full-time. At time of survey, 56% were on sick leave, the majority for full-time. Low self-rated health, poorer health than before diagnosis, having a strenuous work posture, and younger age were associated with sick leave during the initial period after breast cancer surgery in both univariate and multivariate analyses. Discussion. The results of this study is not fully consistent compared to previous studies in this field, often performed in later phases after breast cancer surgery or after other cancer diagnoses. Therefore our results indicate that knowledge is needed during all phases of the breast cancer trajectory to determine factors of importance regarding sick leave and their impact throughout the disease trajectory.

3 December 2018 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
MHMaja Holm
Maja Holm
SDSandra Doveson
Sandra Doveson
OLOlav Lindqvist
Olav Lindqvist
AWAgneta Wennman-Larsen
Agneta Wennman-Larsen
PFPer Fransson
Per Fransson
Quality of Life (QoL) is the most important outcome for patients in palliative care along with symptom alleviation. Metastatic prostate cancer (mPC) is a life-threatening illness, and hence, a palliative care approach may be beneficial to this group. Over time, new life-prolonging treatments have been developed for men with mPC, but the possibility to prolong life should also be balanced against the men’s QoL, particularly because there are side effects involved with these treatments. The aim of this study was to evaluate QoL, functioning and symptoms in men with mPC during their final years before death. This is a retrospective analysis of data from a long-term prospective study of men (n = 3885) with prostate cancer from two regions in Sweden. Validated questionnaires asking about participants’ QoL, functioning and symptoms were used to collect data. From the overall study, 190 men with mPC were identified. They were stratified into three groups, depending on the amount of time that had passed between the last questionnaire and their death; < 6 months, 6–18 months and > 18 months before death. Men with mPC generally rated their QoL poorly compared to established clinically significant threshold values. The group of men that were < 6 months before death rated their QoL, functioning and several symptoms significantly worse than the two other groups. Men that died after the year 2006 reported lower QoL and functioning and more pain and fatigue than those who died before 2006. The results in this study indicate that men with mPC have unmet needs with regards to QoL and symptoms. A palliative care approach, alongside possible life-prolonging treatments, that focuses on QoL and symptom relief, may serve as an important frame to give the best support to these men in their final years of life.

1 December 2014 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
FSFredrik Saboonchi
Fredrik Saboonchi
LPLena-Marie Petersson
Lena-Marie Petersson
AWAgneta Wennman-Larsen
Agneta Wennman-Larsen
KAKristina Alexanderson
Kristina Alexanderson
RBRichard Brännström
Richard Brännström
MVMarjan Vaez
Marjan Vaez